AI Terminal
EAST IMPERIAL PLC
Director's Dealing • Feb 18, 2022
5021_dirs_2022-02-18_f0552f41-d2b5-4eac-be38-778abec348b5.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1431C
East Imperial PLC
18 February 2022
18 February 2022
East Imperial plc
("East Imperial" or the "the Company")
Director/PDMR Shareholding
East Imperial, the global purveyor of ultra-premium beverages, announces that today the Company received notice that Dr. Olufunke Abimbola purchased 50,000 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 9.45 pence per share on 17 February 2022.
- Ends -
Enquiries:
MHP Communications
Peter Hewer +44 (0) 770 9326 261
Rachel Mann +44 (0) 758 5301 464
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr. Olufunke Abimbola
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
East Imperial plc
b)
LEI
213800OI98RNUFC3IG61
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of nominal value 1 pence each
GB00BMZ1ND56
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 9.45p | 50,000 |
d)
Aggregated information
- Aggregated volume
- Price
- Total
50,000
9.45p
£4,725.00
e)
Date of the transaction
17 February 2022
f)
Place of the transaction
London Stock Exchange, Main Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSFISUAEESELE